Rehabilitation of Social Cognition in Subjects With Traumatic Brain Injury

Status Active, not recruiting

Clinical Trial Summary

In the present study the investigators aim to analyze the performance in a battery of social cognition tests of subjects with traumatic brain injury.

On the other hand, the effectiveness of a computerized rehabilitation program designed to improve these deficits will be tested, as well as the relationship between social cognition and executive functioning.

Clinical Trial Description

The ability of the individual to know how to adopt the perspective of the other or be able to interpret and correctly identify their emotions, is essential for their proper development in society. The term Social Cognition would be the construct that would encompass these cognitive processes.

People who have suffered a moderate or severe traumatic brain injury usually show, as reflected in the existing literature, an alteration in the functioning of Social Cognition, leading to problematic or inappropriate behaviors. These deficits have devastating consequences, at a personal, family and economic / labor level.

There is an important debate regarding the independence of the Social Cognition construct from the rest of cognitive functions and in particular with respect to executive functions, probably due to the overlapping of the neuroanatomical structures related to each of these functions.

In the present study a clinical trial will be conducted with a sample of 30 patients admitted to the Guttmann Institute Neurorehabilitation Hospital who have suffered a moderate or severe TBI.

Patients will be divided into two groups depending on whether they receive cognitive rehabilitation treatment focused on attention, memory and executive functions (Control Group) or if, in addition to this treatment, the computerized treatment module for the rehabilitation of CS is also applied. (Experimental Group). Both types of treatment would be carried out using the cognitive telerehabilitation platform Guttmann, NeuroPersonalTrainer® (GNPT).

The purpose of this study is to analyze the altered dimensions in the Social Cognition construct after having suffered a traumatic brain injury and to test the effectiveness of a computerized rehabilitation treatment designed for neuropsychologists with the aim of stimulating the relearning of these skills.

In the same way it is tried to establish and to clarify the existing relation between the construct of the social cognition and other cognitive functions as they can be the executive functions ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03479970
Study type	Interventional
Source	Institut Guttmann
Contact
Status	Active, not recruiting
Phase	N/A
Start date	January 2, 2018
Completion date	January 2, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02488720` - Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Recruiting	`NCT03544801` - Renji Cerebral Small Vessel Disease Corhort Study
Recruiting	`NCT02813434` - Cerebral Amyloid Imaging Using Florbetapir (AV-45)	Phase 3
Completed	`NCT00400790` - Organ Protection for Coronary Artery Bypass Graft (CABG): Propofol Versus Desflurane	N/A
Completed	`NCT00052091` - Therapy for Depressed Elders With Thought Problems	Phase 3
Completed	`NCT00267163` - Brain Imaging and Mental Disorders of Aging Intervention	Phase 4
Completed	`NCT00021866` - Developmental Effects On Children Of Women Who Take Antiepileptic Drugs During Pregnancy	N/A
Not yet recruiting	`NCT04079075` - Multiple Interventions to Prevent Cognitive Decline	N/A
Terminated	`NCT03696082` - A Precision Rehabilitation Approach to Counteract Age-Related Cognitive Declines	N/A
Completed	`NCT02918539` - Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials
Active, not recruiting	`NCT01708837` - Effect of Depth of Total Intravenous Anesthesia Using Propofol on Postoperative Cognitive Dysfunction	Phase 4
Completed	`NCT01290939` - Bevacizumab and Lomustine for Recurrent GBM	Phase 3
Terminated	`NCT00548327` - The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype	Phase 2
Unknown status	`NCT00256425` - Cognitive Rehabilitation of Glioma Patients	Phase 3
Recruiting	`NCT03926351` - High Dose Omega 3 in People at Risk for Dementia	Phase 2
Completed	`NCT02118571` - Schizophrenia Cognition Scale Development	N/A
Completed	`NCT01481961` - Study of Repetitive Transcranial Magnetic Stimulation (rTMS) as add-on Treatment for Early Alzheimer's Disease	N/A
Completed	`NCT00788918` - Study of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS)	N/A
Completed	`NCT00564902` - The Zeaxanthin and Visual Function Study	N/A
Completed	`NCT00529581` - A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Rehabilitation of Social Cognition in Subjects With Traumatic Brain Injury — SOCCER

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms